Position paper on the preparation of immune plasma to be used in the treatment of patients with COVID-19

Passive immunotherapy with plasma derived from patients convalescent from SARS-CoV-2 infection can be a promising approach in the treatment of COVID-19 patients. It is important that Blood Establishments are prepared to satisfy requests for immune plasma by defining the requirements applicable to pl...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Transfusion and apheresis science 2020-08, Vol.59 (4), p.102817-102817, Article 102817
Hauptverfasser:	Accorsi, Patrizia, Berti, Pierluigi, de Angelis, Vincenzo, De Silvestro, Giustina, Mascaretti, Luca, Ostuni, Angelo
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies, Viral - blood Betacoronavirus - immunology Blood Component Removal - methods Blood Donors Coronavirus Infections - blood Coronavirus Infections - immunology Coronavirus Infections - therapy COVID-19 Donor Selection - standards Humans Immune plasma Immune Sera - adverse effects Immune Sera - isolation & purification Immunization, Passive - adverse effects Immunization, Passive - methods Pandemics Pneumonia, Viral - blood Pneumonia, Viral - immunology Pneumonia, Viral - therapy Product Labeling Risk SARS-CoV-2
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!